
We adhere to stringent quality standards, ensuring that our ischemia reperfusion models are reproducible and aligned with GLP principles for reliable scientific outcomes.
Our team comprises seasoned professionals with extensive backgrounds in preclinical research, delivering valuable insights and support throughout your project delivery.
We offer competitive minimum order quantities (MOQ), making it easier for our partners to access the ischemia reperfusion models tailored to their research needs.
From initial inquiries to final reporting, we provide continuous support, ensuring your project runs smoothly and meets all necessary expectations throughout its lifecycle.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china